Oncopeptides partners with veeva to drive more effective engagement ahead of first commercial launch

Pleasanton, calif., may 17, 2021 /prnewswire/ -- veeva systems (nyse: veev) today announced a strategic partnership with oncopeptides to support the launch of the global biotech's first commercial product.

VEEV Ratings Summary

VEEV Quant Ranking